ARCHIVES

New Jersey Commission Calls For Major Hike In Cancer Spending

This article is from The Cancer Letter archive.

Vol. 13 No. 37 | September 25, 1987

Download PDF Visit The Full Archive

Related Articles

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Interferon Results Cool Expectations, But Other Reports At ASCO/AACR Demonstrate Solid Progress

June 6, 1980

Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured

June 16, 1989

Tumors Harder To Detect In Women In Their Forties

August 27, 2010

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

Centers Recruting Patients With Mantle Cell Lymphoma

October 29, 2004